Provided by Tiger Fintech (Singapore) Pte. Ltd.

CSTONE PHARMA-B

4.590
+0.4009.55%
Volume:12.30M
Turnover:56.33M
Market Cap:6.26B
PE:-58.64
High:4.750
Open:4.230
Low:4.200
Close:4.190
Loading ...

CStone Pharmaceuticals Announces New Clinical Trials for Innovative Bispecific Antibodies Targeting Autoimmune Diseases

Reuters
·
12 hours ago

CStone Pharmaceuticals Conducted Annual General Meeting

Reuters
·
25 Jun

CStone Pharmaceuticals Announces Publication of Long-Term Survival Data from GEMSTONE-302 Trial in The Lancet Oncology

Reuters
·
19 Jun

CStone Pharmaceuticals CEO Boosts Shareholding

MT Newswires Live
·
09 Apr

BRIEF-Cstone Pharmaceuticals Announces Further Increase In Shareholding By CEO

Reuters
·
09 Apr

CStone Pharmaceuticals - Further Increase in Shareholding by CEO and Executive Director

THOMSON REUTERS
·
09 Apr

CStone Pharmaceuticals - CEO Purchased 560,000 Shares From April 2 to 7 With Purchase Price per Share Ranging From HKD2.26 to HKD3.29

THOMSON REUTERS
·
09 Apr

Stock Track | CStone Pharma Plummets 5.20% as 2024 Earnings Miss Expectations

Stock Track
·
03 Apr

CStone Pharmaceuticals Full Year 2024 Earnings: Misses Expectations

Simply Wall St.
·
03 Apr

BUZZ-CStone Pharmaceuticals hits 5-week low on discounted share sale

Reuters
·
02 Apr

Stock Track | CStone Pharmaceuticals Plummets 8.70% on Share Placement Announcement

Stock Track
·
02 Apr

CStone Pharmaceuticals to Raise HK$232 Million from Share Placement

MT Newswires Live
·
02 Apr

BRIEF-Cstone Pharmaceuticals To Place Aggregate Of 80 Million Placing Shares

Reuters
·
02 Apr

CStone Pharmaceuticals - to Place Aggregate of 80 Mln Placing Shares at HK$2.933 per Share

THOMSON REUTERS
·
02 Apr

BRIEF-CStone Pharmaceuticals Announces 2024 Annual Results And Recent Business Progress

Reuters
·
27 Mar

CStone Pharmaceuticals Announces 2024 Annual Results and Recent Business Progress

THOMSON REUTERS
·
27 Mar

Press Release: CStone Pharmaceuticals Announces 2024 Annual Results and Recent Business Progress

Dow Jones
·
27 Mar

CStone Pharmaceuticals - Revenue Was RMB407.2 Mln for Year

THOMSON REUTERS
·
27 Mar

CStone Seeks EU Approval for New Indication of Lung Cancer Drug

MT Newswires Live
·
24 Mar

CStone Submits Application to the European Medicines Agency for New Indication of Sugemalimab in Stage Iii Non-Small Cell Lung Cancer

THOMSON REUTERS
·
24 Mar